Skip to main content

Biotechnology Bounce Can Continue

The SPDR S&P Biotech ETF (NYSEArca: XBI), which rallied earlier this week amid some deal-making in the sector, is up 7.70% this month and some market observers believe biotechnology stock can extend their recent bullishness. XBI one of the largest biotechnology exchange traded funds (ETFs), has...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.